Russell Alan J
SEC CIK 1853529 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | CSO, Dir | 37.4K | — | $23.50M | 36 | 2021-09-23 | 2026-08-12 |
Most active insiders at EWTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Russell Alan J | CSO, Dir | — | $10.25M |
| 2 | Donovan Joanne M. | CMO | — | $4.62M |
| 3 | Edris Badreddin | Dir | — | $3.40M |
| 4 | KOCH KEVIN | Pres, CEO, Dir | — | $785.0K |
| 5 | Derakhshan Behrad | Chief Business Off | — | $223.4K |
| 6 | MOORE JOHN R | GC | — | $219.8K |
| 7 | Fox Jonathan C | Dir | $199.4K | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-14 16:53 | 2026-08-12 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.00 | +12.8K | 37.4K | +52% | $0 |
| DM | 2026-08-14 16:53 | 2026-08-12 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $43.73 | -5,901 | 31.5K | -16% | -$258.0K |
| DMT | 2026-07-02 17:21 | 2026-07-01 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.356 | +200.0K | 224.6K | +814% | +$71.2K |
| DMT | 2026-07-02 17:21 | 2026-07-01 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $39.41 | -200.0K | 24.6K | -89% | -$7.88M |
| D | 2025-11-13 | 2025-11-12 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $21.12 | -100.0K | 23.4K | -81% | -$2.11M |
| D | 2025-11-13 | 2025-11-12 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.18 | +100.0K | 123.4K | +427% | +$18.0K |
| D | 2025-08-28 | 2025-08-26 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $14.60 | -100.0K | 23.4K | -81% | -$1.46M |
| D | 2025-08-28 | 2025-08-26 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.18 | +100.0K | 123.4K | +427% | +$18.0K |
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $13.39 | -1,907 | 23.4K | -8% | -$25.5K |
| D | 2025-08-14 | 2025-08-12 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.00 | +5,781 | 25.3K | +30% | $0 |
| D | 2025-05-07 | 2025-05-02 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $16.45 | -1,551 | 18.5K | -8% | -$25.5K |
| D | 2025-05-07 | 2025-05-01 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.00 | +5,209 | 20.1K | +35% | $0 |
| DT | 2025-03-11 | 2025-03-07 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.18 | +200 | 15.1K | +1% | +$36 |
| DT | 2025-03-11 | 2025-03-07 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $30.02 | -200 | 14.9K | -1% | -$6,004 |
| DMT | 2025-02-07 | 2025-02-05+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.18 | +9,215 | 16.1K | +135% | +$1,659 |
| DMT | 2025-02-07 | 2025-02-05+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $30.03 | -9,215 | 14.9K | -38% | -$276.8K |
| DT | 2024-12-31 | 2024-12-30 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.18 | +100.0K | 114.9K | +673% | +$18.0K |
| DT | 2024-12-31 | 2024-12-30 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $27.37 | -100.0K | 14.9K | -87% | -$2.74M |
| DM | 2024-09-24 | 2024-09-20 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $28.26 | -75.0K | 12.7K | -86% | -$2.12M |
| D | 2024-09-24 | 2024-09-20 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.18 | +75.0K | 87.7K | +590% | +$13.5K |
| D | 2024-05-03 | 2024-05-02 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $18.91 | -1,576 | 7,238 | -18% | -$29.8K |
| D | 2024-05-03 | 2024-05-01 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.00 | +5,208 | 8,814 | +144% | $0 |
| 2023-12-28 | 2023-12-26 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $9.33 | -172.6K | 3,606 | -98% | -$1.61M | |
| D | 2023-05-03 | 2023-05-01 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | M - OptEx | $0.00 | +5,208 | 177.8K | +3% | $0 |
| D | 2023-05-03 | 2023-05-02 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale+OE | $8.90 | -1,602 | 176.2K | -0.9% | -$14.3K |
| DM | 2021-12-01 | 2021-11-30 | EWTX | Edgewise Therapeutics, Inc. | CSO, Dir | M - OptEx | $0.2191 | +172.6K | 172.6K | New | +$37.8K | |
| M | 2021-11-17 | 2021-11-15 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $19.11 | -479 | 0 | -100% | -$9,155 |
| M | 2021-11-12 | 2021-11-09+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $19.91 | -69.7K | 40.6K | -63% | -$1.39M |
| M | 2021-11-08 | 2021-11-04+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $19.82 | -29.5K | 92.3K | -24% | -$583.7K |
| M | 2021-11-03 | 2021-11-01+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $17.88 | -44.2K | 99.7K | -31% | -$789.9K |
| M | 2021-10-18 | 2021-10-14+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $18.17 | -7,182 | 143.8K | -5% | -$130.5K |
| 2021-10-13 | 2021-10-11 | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $18.02 | -1,270 | 151.0K | -0.8% | -$22.9K | |
| M | 2021-10-08 | 2021-10-06+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $18.39 | -21.0K | 158.2K | -12% | -$386.7K |
| M | 2021-10-05 | 2021-10-01+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $18.24 | -5,778 | 178.7K | -3% | -$105.4K |
| M | 2021-09-30 | 2021-09-28+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $17.10 | -26.5K | 190.9K | -12% | -$452.5K |
| M | 2021-09-27 | 2021-09-23+ | EWTX | Edgewise Therapeutics, Inc. | Russell Alan J | CSO, Dir | S - Sale | $18.30 | -58.5K | 237.3K | -20% | -$1.07M |
Purchase Sale Sale after option exercise All abbreviations